174 related articles for article (PubMed ID: 3516514)
41. Intracystic evaluation of tumor markers in benign and malignant ovarian pathology.
Cherchi PL; Capobianco G; Ambrosini G; Fadda GM; Piga MD; Ruiu G; Fattorini F; Dessole S
Eur J Gynaecol Oncol; 2002; 23(2):163-5. PubMed ID: 12013118
[TBL] [Abstract][Full Text] [Related]
42. [Clinical significance of beta 2-microglobulin and carcinoembryonic antigen in intracranial tumors].
Suzuki Y; Ishii R; Otsuka R; Ogawa Y; Kikuoka M; Hirano K; Tanaka R
No To Shinkei; 1987 Oct; 39(10):965-70. PubMed ID: 3325088
[TBL] [Abstract][Full Text] [Related]
43. [Cystadenoma of the liver with high levels of ACE and CA 19-9 in the cyst].
Trésallet C; Jordi-Galais P; Nguyen-Thanh Q; Aubriot-Lorton MH; Costedoat-Chalumeau N; Chigot JP; Menegaux F
Gastroenterol Clin Biol; 2003 Apr; 27(4):413-5. PubMed ID: 12759683
[TBL] [Abstract][Full Text] [Related]
44. The lactate dehydrogenases in malignant and non-malignant diseases.
Oladipo OO; Ajala MO; Afonja OA
Niger Postgrad Med J; 2002 Mar; 9(1):1-6. PubMed ID: 11932752
[TBL] [Abstract][Full Text] [Related]
45. CA 125 in ovarian cysts, serous effusions and peritoneal washings: immunocytochemical expression.
Carico E; Chicchirichi R; Atlante M; Giovagnoli M; Vecchione A
Anticancer Res; 1995; 15(2):631-4. PubMed ID: 7763049
[TBL] [Abstract][Full Text] [Related]
46. [Benign cysts of the ovary. Homogeneous experience in 22 cases observed in 10 years].
Scheye T; Rodier JF; Vanneuville G; Souteyrand P; Dechelotte P; Billet P; Lesec G; Vorilhon P
Chir Pediatr; 1986; 27(4):185-9. PubMed ID: 3545515
[TBL] [Abstract][Full Text] [Related]
47. [Lactate dehydrogenase isoenzyme spectral characteristics in the blood serum of patients with hormone-dependent tumors].
Shukurian SG; Makhmurian TD; Khachatrian AG; Chil-Akopian LA; Karapetian NV; Bakajanian AP
Zh Eksp Klin Med; 1979; 19(3):85-90. PubMed ID: 494894
[No Abstract] [Full Text] [Related]
48. [Mucin histochemical and immunohistochemical studies of mucinous ovarian tumors].
Shi ZL
Zhonghua Bing Li Xue Za Zhi; 1989 Sep; 18(3):201-3. PubMed ID: 2636063
[TBL] [Abstract][Full Text] [Related]
49. Characterization of the carcinoembryonic antigen activity associated with cyst fluids of mucinous ovarian cystadenocarcinoma.
Yamashita K; Aitio ML; Dawson JR
Cancer Res; 1979 May; 39(5):1760-5. PubMed ID: 85489
[TBL] [Abstract][Full Text] [Related]
50. DNA ploidy of ovarian and adnexal cyst fluid. A useful adjunct to cytology.
Greenebaum E; Yee HT; Liu J
Acta Cytol; 1994; 38(2):201-8. PubMed ID: 8147211
[TBL] [Abstract][Full Text] [Related]
51. [Demonstration of immunoglobulins, glycoproteins and beta 2 microglobulin in ovarian cysts and cystic ovarian tumors].
Briese V; Brock J; Lorenz U; Straube W
Zentralbl Gynakol; 1982; 104(21):1348-54. PubMed ID: 6187139
[TBL] [Abstract][Full Text] [Related]
52. Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group.
Timmerman D; Testa AC; Bourne T; Ferrazzi E; Ameye L; Konstantinovic ML; Van Calster B; Collins WP; Vergote I; Van Huffel S; Valentin L;
J Clin Oncol; 2005 Dec; 23(34):8794-801. PubMed ID: 16314639
[TBL] [Abstract][Full Text] [Related]
53. Carcinoembryonic antigen in primary and metastatic ovarian tumors.
Fleuren GJ; Nap M
Gynecol Oncol; 1988 Jul; 30(3):407-15. PubMed ID: 2839395
[TBL] [Abstract][Full Text] [Related]
54. The cytologic application of carcinoembryonic antigen for the discrimination of malignant from benign serous effusions.
Kyrkou KA; Iatridis SG; Athanassiadou PP; Athanassiadis PP; Mandragos CE
Cancer Detect Prev; 1985; 8(1-2):247-54. PubMed ID: 4064045
[TBL] [Abstract][Full Text] [Related]
55. Elevated serum RANTES levels in patients with ovarian cancer correlate with the extent of the disorder.
Tsukishiro S; Suzumori N; Nishikawa H; Arakawa A; Suzumori K
Gynecol Oncol; 2006 Sep; 102(3):542-5. PubMed ID: 16510173
[TBL] [Abstract][Full Text] [Related]
56. TPS and CA 125 levels in serum, cyst fluid and ascites of patients with epithelial ovarian neoplasms.
Harłozinska A; Sedlaczek P; Van Dalen A; Rozdolski K; Einarsson R
Anticancer Res; 1997; 17(6D):4473-8. PubMed ID: 9494553
[TBL] [Abstract][Full Text] [Related]
57. Diffusion-weighted echo-planar MR imaging and ADC mapping in the differential diagnosis of ovarian cystic masses: usefulness of detecting keratinoid substances in mature cystic teratomas.
Nakayama T; Yoshimitsu K; Irie H; Aibe H; Tajima T; Nishie A; Asayama Y; Matake K; Kakihara D; Matsuura S; Nakano H; Honda H
J Magn Reson Imaging; 2005 Aug; 22(2):271-8. PubMed ID: 16028258
[TBL] [Abstract][Full Text] [Related]
58. [Mucopolysaccharides in tumors of the ovaries].
Toreushina NS; Kozhevnikova IN; Zefirova NP
Vopr Onkol; 1969; 15(8):37-40. PubMed ID: 4311343
[No Abstract] [Full Text] [Related]
59. Are serum and biliary carcinoembryonic antigen and carbohydrate antigen19-9 determinations reliable for differentiation between benign and malignant biliary disease?
Akdoğan M; Parlak E; Kayhan B; Balk M; Saydam G; Sahin B
Turk J Gastroenterol; 2003 Sep; 14(3):181-4. PubMed ID: 14655062
[TBL] [Abstract][Full Text] [Related]
60. Ultrasonography in the diagnosis of tumors of the ovary.
DeLand M; Fried A; van Nagell JR; Donaldson ES
Surg Gynecol Obstet; 1979 Mar; 148(3):346-8. PubMed ID: 419432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
